The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects

Ege T Kavalali; Lisa M Monteggia

doi:10.1038/npp.2017.210

The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects

Ege T Kavalali, Lisa M Monteggia

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	221-222
Number of pages	2
Journal	Neuropsychopharmacology
Volume	43
Issue number	1
DOIs	https://doi.org/10.1038/npp.2017.210
State	Published - Jan 1 2018

ASJC Scopus subject areas

Pharmacology
Psychiatry and Mental health

Access to Document

10.1038/npp.2017.210

Cite this

@article{931328445ed14d8793500eb05f906546,

title = "The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects",

author = "Kavalali, {Ege T} and Monteggia, {Lisa M}",

note = "Funding Information: This work was supported by National Institutes of Health Grants MH070727 (LMM) and MH066198 (ETK). LMM is a consultant for Fortress Biotech. ETK declares no conflict of interest.",

year = "2018",

month = jan,

day = "1",

doi = "10.1038/npp.2017.210",

language = "English (US)",

volume = "43",

pages = "221--222",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects

AU - Kavalali, Ege T

AU - Monteggia, Lisa M

N1 - Funding Information: This work was supported by National Institutes of Health Grants MH070727 (LMM) and MH066198 (ETK). LMM is a consultant for Fortress Biotech. ETK declares no conflict of interest.

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85036666356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85036666356&partnerID=8YFLogxK

U2 - 10.1038/npp.2017.210

DO - 10.1038/npp.2017.210

M3 - Article

C2 - 29192654

AN - SCOPUS:85036666356

SN - 0893-133X

VL - 43

SP - 221

EP - 222

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

IS - 1

ER -

The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this